New Drugs and Biologics 2023: Therapies Reaching the Home and Alternate Site Infusion Space - INFUSION Article

This article will provide education on FDA-approved drugs from 2023 that are relevant to the home and alternate site infusion industry due to their administration via intravenous infusion, subcutaneous infusion, or injection. Each drug will be reviewed briefly, focusing on its indication, the incidence and clinical course of the treated disease(s), and its mechanism of action. The review will also include information on the clinical trials leading to FDA approval, considerations for home infusion pharmacies regarding drug storage, compounding, and administration, nursing and patient education requirements, and pricing details. This activity is designed for pharmacists, pharmacy technicians, and nurses.

Learning Objectives:

  1. Review the new FDA approved drugs approved in 2023 that relate to the home and specialty infusion industry.
  2. Understand the indications for the new FDA drugs approved in 2023.
  3. Review the clinical characteristics of the new FDA drugs approved in 2023.
  4. Discuss clinical, compounding, administration, and nursing considerations for the FDA approved drug in 2023

NHIA General CE Information

Ryan Garst, PharmD, MBA, IgCP, BCSCP

Vice President of Pharmacy

Nutrishare Inc

Ryan Garst, Pharm D, MBA, BCSCP is the Senior Director of Clinical Services at the National Home Infusion Association. Garst has almost 15 years of experience in home infusion and nearly twenty years of experience in pharmacy clinical and operational leadership and management, information technology, sales, and clinical practice experience. At NHIA, Garst is responsible for clinical education and services, Infusion Magazine Clinical Editor, and oversees a variety of programs administered by the National Home Infusion Foundation including the industry resident program, the National Benchmarking Program, and clinical trials and research. Prior to joining NHIA, Garst served on a variety of committees for the association and participated in numerous annual conferences. Garst holds a Doctor of Pharmacy degree from Ohio Northern University and a Master of Business Administration from Kent State University and is Board Certified in Sterile Compounded Preparations via BPS.

NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

Ryan Garst has no relevant financial relationships with ineligible companies to disclose.

Key:

Complete
Failed
Available
Locked
New Drugs and Biologics 2023
Open to download resource.
Open to download resource.
You must register to access.
Post Education Survey
8 Questions
8 Questions New Drugs and Biologics 2023: Therapies Reaching the Home and Alternate Site Infusion Space INFUSION Article 2.0 CE JA4008389-0000-25-028-H01-P&T & 202895637-RN&RD
You must register to access.
INFUSION Reader Survey
Select the "INFUSION Reader Survey" button to begin.
Select the "INFUSION Reader Survey" button to begin.
You must register to access.
Required to Claim CE
Up to 2.00 medical credits available  |  Certificate available
Up to 2.00 medical credits available  |  Certificate available **PHARMACISTS & PHARMACY TECHNICIANS MUST SELECT THE BLUE "CLAIM CREDIT" BUTTON & ENTER YOUR DOB IN ORDER TO RECEIVE CE CREDIT** ________________________________________________________________________________________________________________________________________________________________________ NHIA adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME/CE activity, including faculty, panelists, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. Please note that the certificates printed from this platform are invalid as proof of continuing education (CE). For official documentation of CE credits, please print a paper statement of credit from your NABP e-profile.
You must register to access.